Contact us : info@bioworlde.com
Home > Product > Primary Antibodies
PDGF-B (L48) polyclonal antibody BS1290
  • Western blot (WB) analysis of PDGF-B (L48) pAb at 1:500 dilution Lane1:HepG2 whole cell lysate(40ug) Lane2:3T3-L1 whole cell lysate(40ug) Lane3:H9C2 whole cell lysate(40ug) Lane4:H1792 whole cell lysate(40ug) Lane5:Hela whole cell lysate(40ug) Lane6:HEK293T whole cell lysate(40ug)
  • Immunohistochemistry (IHC) analyzes of PDGF-B (L48) pAb in paraffin-embedded human breast carcinoma tissue at 1:50.
Product NamePDGF-B (L48) polyclonal antibody
Catalog No.BS1290
Swiss-ProtP01127
Host Rabbit
ReactivityHuman,Mouse,Rat
ApplicationsWB IHC
Application_allWB: 1:500~1:1000 IHC: 1:50~1:200
BiowMW~ 27 kDa
Alternative NamePlatelet-derived growth factor subunit B; PDGF subunit B; PDGF-2; Platelet-derived growth factor B chain; Platelet-derived growth factor beta polypeptide; Proto-oncogene c-Sis; Becaplermin; PDGFB; PDGF2; SIS
Purification&PurityThe antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).
ConjugateUnconjugated
ModificationUnmodification
Browse similar products>>
Size Price
50ul $158
100ul $275
Add to cart My orders
Product Name :
PDGF-B (L48) polyclonal antibody
Background :
PDGF is a mitogen for mesenchyme- and glia-derived cells. It consists of two disulfide-bonded polypeptide chains, A and B, and occurs as three isoforms, PDGF AA, PDGF AB and PDGF BB. The three isoforms bind with different affinities to two receptor types, α and β, which are structurally related and endowed with protein-tyrosine kinase domains. Ligand binding induces activation of the receptor kinases by formation of receptor dimers; the A subunit of PDGF binds only to α receptors with high affinity, whereas the B subunit can bind to both α and β receptors. Evidence suggests that PDGF may function as a neurotrophic factor.
Product :
Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2
Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Specificity :
PDGFB (L48) polyclonal antibody detects endogenous levels of PDGFB protein.
Immunogen :
Synthetic peptide, corresponding to amino acids 21-70 of Human PDGF-B.
Conjugate :
Unconjugated
Modification :
Unmodification
  • Western blot (WB) analysis of PDGF-B (L48) pAb at 1:500 dilution Lane1:HepG2 whole cell lysate(40ug) Lane2:3T3-L1 whole cell lysate(40ug) Lane3:H9C2 whole cell lysate(40ug) Lane4:H1792 whole cell lysate(40ug) Lane5:Hela whole cell lysate(40ug) Lane6:HEK293T whole cell lysate(40ug)
  • Immunohistochemistry (IHC) analyzes of PDGF-B (L48) pAb in paraffin-embedded human breast carcinoma tissue at 1:50.
Hypoxia-inducible Factor Activation in Myeloid Cells Contributes to the Development of Liver Fibrosis in Cholestatic Mice PMCID:    Pubmed No.:22271822 Cigarette Smoke Extract Stimulates Rat Pulmonary Artery Smooth Muscle Cell Proliferation via PKC-PDGFB Signaling PMCID:    Pubmed No.:22754279 VEGF/VEGFR2 and PDGF-B/PDGFR-β expression in non-metastatic renal cell carcinoma: a retrospective study in 1,091 consecutive patients PMCID:    Pubmed No.:25550804 Combination of IL-24 and cisplatin inhibits angiogenesis and lymphangiogenesis of cervical cancer xenografts in a nude mouse model by inhibiting VEGF, VEGF-C and PDGF-B. PMCID:    Pubmed No.:25778843 Specific chemotherapeutic agents induce metastatic behaviour through stromal‐and tumour‐derived cytokine and angiogenic factor signalling PMCID:    Pubmed No.:25988668 Prognostic significance of platelet-derived growth factor receptor-β expression in localized clear cell renal cell carcinoma PMCID:    Pubmed No.:26215891 VEGF/VEGFR2 and PDGF-B/PDGFR-β expression in non-metastatic renal cell carcinoma: a retrospective study in 1,091 consecutive patients PMCID:    Pubmed No.:25550804 Prognostic significance of platelet-derived growth factor receptor-β expression in localized clear cell renal cell carcinoma PMCID:    Pubmed No.:26215891 Combination of IL-24 and cisplatin inhibits angiogenesis and lymphangiogenesis of cervical cancer xenografts in a nude mouse model by inhibiting VEGF, VEGF-C and PDGF-B PMCID:    Pubmed No.:25778843 Randomized phase II study of capecitabine plus cisplatin with or without sorafenib in patients with metastatic gastric cancer (STARGATE) PMCID:    Pubmed No.:36515003 Synergistic therapeutic combination with a CAF inhibitor enhances CAR-NK-mediated cytotoxicity via reduction of CAF-released IL-6 PMCID:    Pubmed No.:36849201 Therapeutic effects of axitinib, an anti-angiogenic tyrosine kinase inhibitor, on interstitial cystitis PMCID:    Pubmed No.:37221266
Bioworld Biotech only provide peptides for our antibodies and do not provide additional peptide customization services.

Price/Size :

USD 368/1mg/vial



Tips: 

For phospho antibody, we provide phospho peptide(0.5mg) and non-phospho peptide(0.5mg).

Describe :

Blocking peptides are peptides that bind specifically to the target antibody and block antibody binding. These peptide usually contains the epitope recognized by the antibody. Antibodies bound to the blocking peptide no longer bind to the epitope on the target protein. This mechanism is useful when non-specific binding is an issue, for example, in Western blotting (WB) and Immunohistochemistry (IHC). By comparing the staining from the blocked antibody versus the antibody alone, one can see which staining is specific; Specific binding will be absent from the western blot or IHC performed with the neutralized antibody.

Formula:

Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 10 mg/ml.The purity is >90%,tested by HPLC and MS.

Storage:

The freeze-dried powder is more stable. For short time at 2-8°C. For long term storage store at -20°C. 


Note :

This product is for research use only (RUO only). Not for use in diagnostic or therapeutic procedures.
COPYRIGHT © 2015-2018 Bioworld Technology, Inc. All rights reserved POLYCLONAL AND MONOCLONAL ANTIBODY CENTER